Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.68Price to Book
VS
Market
Sector
Industry
History
$ 17.38Close
$ 7.8 - $ 29.6 52-Week Range
Ticker Information
Ticker
LYELCompany Name
LYELL IMMUNOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLYELL IMMUNOPHARMA INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LYEL - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 298.92M | $ 203.06M | 0.68 |
| 3/31/2025 | $ 336.52M | $ 119.49M | 0.36 |
| 12/31/2024 | $ 382.82M | $ 196.53M | 0.51 |
| 9/30/2024 | $ 530.7M | $ 340.65M | 0.64 |
| 6/30/2024 | $ 566.5M | $ 360.96M | 0.64 |
| 3/31/2024 | $ 603.16M | $ 647.55M | 1.07 |
| 12/31/2023 | $ 654.95M | $ 721.63M | 1.1 |
| 9/30/2023 | $ 697.57M | $ 566.71M | 0.81 |
| 6/30/2023 | $ 736.86M | $ 602.46M | 0.82 |
| 3/31/2023 | $ 783.83M | $ 604.05M | 0.77 |
Key Performance Insights, Last 5 Years
- LYELL IMMUNOPHARMA INC's latest trailing twelve months (TTM) P/B stands at 0.
- Over the past 5 years, LYELL IMMUNOPHARMA INC's average P/B has been 1.21.
- The median P/B for LYELL IMMUNOPHARMA INC during this period was 0.82
- LYELL IMMUNOPHARMA INC reached its highest P/B over the past 5 years at 3.35.
- The lowest P/B recorded by LYELL IMMUNOPHARMA INC in the same timeframe 0.36
LYELL IMMUNOPHARMA INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for LYELL IMMUNOPHARMA INC is calculated as follows: Market Cap [ $ 0 ] / Equity [ $ -292.53M ]
(=) P/B [ 0 ] LYEL - Price to Book, Last 5 years
0.36
Minimum
Mar 31, 2025
3.35
Maximum
Jun 30, 2021
1.21
Average
0.82
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.3 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.3 |
| median | 1.63 |
| std | 1.81 |